Related Experiment Video
Updated: May 27, 2025

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Exploring the therapeutic potential of natural products in modulating miRNA networks in prostate cancer
1Department of Pharmacology, College of Medicine, University of Bisha, 61922, Bisha, Saudi Arabia. oamohamed@ub.edu.sa.
Abstract:
Prostate cancer (PC) is the most common cancer among men and the second leading cause of cancer-related deaths in the USA. It remains a significant health challenge, necessitating the exploration of novel therapeutic strategies. It primarily manifests as adenocarcinoma, which arises from glandular cells in the prostate gland, located below the bladder. While many men may not experience symptoms in the early stages, as the disease progresses, symptoms can include difficulty urinating, erectile dysfunction, and pelvic or back pain. MicroRNAs (miRNAs) are small, non-coding RNA molecules, typically consisting of 21 to 23 nucleotides, that play a vital role in regulating gene expression. miRNAs are found across a variety of organisms, including plants, animals, and some viruses. Their primary function is to modulate the expression of target genes, thereby influencing numerous biological processes such as development, differentiation, proliferation, and apoptosis. Natural compounds such as curcumin, ellagitannin, diindolylmethane, epigallocatechin-3-gallate (EGCG), resveratrol, genistein, luteolin, capsaicin, and berberine have been shown to modulate miRNA expression in PC, contributing to their anticancer effects. These compounds influence the expression of both tumor-suppressor and oncogenic miRNAs, thereby impacting critical pathways related to cell proliferation, apoptosis, and metastasis. Recent studies indicate that the deregulation of miRNA networks plays a critical role in cancer progression, and natural compounds have emerged as potential modulators of these pathways. Through a comprehensive literature survey, we identified various phytochemicals that exhibit anticancer properties by influencing miRNA expression. These natural agents can alter miRNA levels through direct binding, epigenetic modifications, or interaction with proteins involved in miRNA biogenesis. The findings underscore the potential of integrating natural agents into therapeutic approaches for PC, paving the way for innovative miRNA-targeted treatments. This review not only elucidates the molecular mechanisms underlying the health benefits of natural compounds but also highlights their promise in developing effective cancer therapies.
Insights
Natural compounds modulate microRNAs (miRNAs) to combat prostate cancer (PC). These agents influence tumor suppressors and oncogenes, offering a promising avenue for novel PC therapies.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Prostate cancer (PC) is a leading cause of cancer-related deaths in men, highlighting the need for new treatments.
- MicroRNAs (miRNAs) are key regulators of gene expression involved in numerous cellular processes, including cancer development.
- Deregulation of miRNA networks is implicated in prostate cancer progression.
Purpose of the Study:
- To review the role of natural compounds in modulating miRNA expression for prostate cancer therapy.
- To explore the molecular mechanisms by which phytochemicals impact miRNA networks in PC.
Main Methods:
- Comprehensive literature survey of studies investigating natural compounds and their effects on miRNA expression in prostate cancer.
- Analysis of identified phytochemicals and their mechanisms of action on miRNA biogenesis and function.
Main Results:
- Various natural compounds (e.g., curcumin, EGCG, resveratrol) modulate both tumor-suppressor and oncogenic miRNAs in PC.
- These compounds influence critical pathways regulating cell proliferation, apoptosis, and metastasis.
- Natural agents alter miRNA levels via direct binding, epigenetic modifications, or interaction with miRNA biogenesis machinery.
Conclusions:
- Natural compounds show significant potential as modulators of miRNA networks in prostate cancer.
- Phytochemicals can be integrated into therapeutic strategies for PC, leading to innovative miRNA-targeted treatments.
- Understanding these mechanisms provides a basis for developing effective natural product-based cancer therapies.
Related Concept Videos
MicroRNAs
Drugs that Stabilize Microtubules
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Targeted Cancer Therapies
There are several types of targeted therapies against...

